Belamaf and Dexamethasone – Safe, Effective Multiple Myeloma Treatment
/ Evangelos Terpos / Jan Andreasen
High Expression of the Inhibitory Checkpoint Receptor TIGIT by CD8+ T-cells in Multiple Myeloma
/ Katrine Fladeland Iversen
ASH 2022: Nye behandlingsmuligheter for myelomatose
/ Fredrik Schjesvold
Evidence to use MRD after induction therapy of AML
/ Jacqueline Cloos
DREAMM-2-studien ga grunnlaget for ny BCMA-rettet behandling av multippelt myelom
/ BestPractice Nordic
Belantamab mafodotin godkjent for behandling av multippelt myelom
/ BestPractice Nordic